Economic analysis of paliperidone long-acting injectable for chronic schizophrenia in Portugal-Reference-Cited by-同舟云学术

Economic analysis of paliperidone long-acting injectable for chronic schizophrenia in Portugal

Published:2016-05-13 Issue:9 Volume:19 Page:913-921
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Einarson Thomas R.¹,Maia-Lopes Susana²,Goswami Pushpendra³,Bereza Basil G.¹,Van Impe Kristel³

Affiliation:

1. Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada;

2. Janssen-Cilag Farmacêutica Lda, Barcarena, Portugal;

3. Janssen-Cilag GmbH, Neuss, Germany

Funder

Janssen Pharmaceuticals

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2016.1184156

Reference84 articles.

1. Wilkinson R, Pickett K. The spirit level: why equality is better for everyone. London: The Equality Trust, 2009. http://www.equalitytrust.org.uk/. Accessed July 7, 2015

2. The Global Costs of Schizophrenia

3. Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients*

4. Quality of life in bipolar type I disorder and schizophrenia in remission: Clinical and neurocognitive correlates

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bench-Scale Microfluidic Manufacturing of Cross-Linked Polyester Microparticles;ACS Applied Polymer Materials;2024-08-14

2. Real-World Cost-analysis of Paliperidone Palmitate for Schizophrenia Management:A Retrospective Analysis in Xiamen, China;2024-04-17

3. Real-World Pharmacoeconomic Assessment of Paliperidone Palmitate for Schizophrenia Management:A Retrospective Analysis;2023-09-08

4. Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal;Drug, Healthcare and Patient Safety;2023-09

5. Cost-effectiveness analysis of monthly, 3-monthly, and 6-monthly long-acting injectable and oral paliperidone in adults with schizophrenia;Journal of Managed Care & Specialty Pharmacy;2023-08